California Public Employees Retirement System Cabaletta Bio, Inc. Transaction History

California Public Employees Retirement System

$161 Billion
Q3 2025

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$7.2 - $11.73 $187,920 - $306,153	-26,100 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$10.39 - $14.53 $26,723 - $37,371	-2,572 Reduced 8.97%	26,100 $290,000
Q3 2020 Nov 05, 2020	BUY	$9.71 - $14.41 $278,405 - $413,163	28,672 New	28,672 $311,000

Others Institutions Holding CABA

# of Institutions

Shares Held

72.8M

Call Options Held

1.1M

Put Options Held

14.9K

Bain Capital Life Sciences Investors, LLC Boston, MA

9.68M
Shares

$22.4 Million
7.24% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.83M
Shares

$20.4 Million
0.03% of portfolio
Jennison Associates LLC

8.5M
Shares

$19.6 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

8.36M
Shares

$19.3 Million
0.01% of portfolio
Cormorant Asset Management, LP Boston, MA

5M
Shares

$11.6 Million
1.86% of portfolio

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $67M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account